Geode Capital Management, LLC Theseus Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$2.12 - $4.18 $4,757 - $9,379	2,244 Added 0.55%	407,822 $1.65 Million
Q3 2023 Nov 13, 2023	SELL	$2.66 - $10.04 $42,411 - $160,077	-15,944 Reduced 3.78%	405,578 $1.09 Million
Q2 2023 Aug 11, 2023	BUY	$7.28 - $11.82 $681,786 - $1.11 Million	93,652 Added 28.56%	421,522 $3.93 Million
Q1 2023 May 15, 2023	BUY	$5.21 - $14.05 $147,255 - $397,109	28,264 Added 9.43%	327,870 $2.91 Million
Q4 2022 Feb 13, 2023	BUY	$4.69 - $8.36 $57,269 - $102,083	12,211 Added 4.25%	299,606 $1.49 Million
Q3 2022 Nov 14, 2022	BUY	$5.7 - $8.68 $178,159 - $271,302	31,256 Added 12.2%	287,395 $1.67 Million
Q2 2022 Aug 12, 2022	BUY	$5.04 - $14.05 $270,663 - $754,527	53,703 Added 26.53%	256,139 $1.42 Million
Q1 2022 May 13, 2022	BUY	$8.75 - $14.51 $90,903 - $150,744	10,389 Added 5.41%	202,436 $2.33 Million
Q4 2021 Feb 11, 2022	BUY	$8.98 - $20.09 $1.72 Million - $3.86 Million	192,047 New	192,047 $2.44 Million

1.03M

Ticker THRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,713,400
Description
Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.